Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
June 8, 2011 | Journal Article
More stringent evaluation of orphan drug trials is recommended to ensure safety and efficacy.
Clinical Trials
You are now viewing 1 - 2 of 2 results
Sort results by:
Should FDA Require Drug Manufacturers to Test Effects of New Drugs on Varying Populations?
January 4, 2011 | Human Capital Blog Post
RWJF Scholars in Health Policy Research National Program Director Alan B. Cohen, Sc.D., had a letter in the December 29, 2010 New York Times (Avastin: Judging the Risks vs. Benefits), noting that Food & Drug Administration (FDA) approval of new drug ...